These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35807179)

  • 1. The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland.
    Bogdanet D; Toth Castillo M; Doheny H; Dervan L; Luque-Fernandez MA; Halperin JA; O'Shea PM; Dunne FP
    J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland.
    Bogdanet D; Toth Castillo M; Doheny H; Dervan L; Angel Luque-Fernandez M; Halperin J; O'Shea PM; Dunne FP
    Diabetes Res Clin Pract; 2022 Aug; 190():110023. PubMed ID: 35907507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening.
    Bogdanet D; Castillo MT; Doheny H; Dervan L; Luque-Fernandez MA; Halperin J; O'Shea PM; Dunne FP
    Diabet Med; 2023 Sep; 40(9):e15121. PubMed ID: 37078256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland.
    Bogdanet D; Castillo MT; Doheny H; Dervan L; Luque-Fernandez MA; Halperin JA; O'Shea PM; Dunne FP
    Acta Diabetol; 2023 Feb; 60(2):211-223. PubMed ID: 36309618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns.
    Ma D; Luque-Fernandez MA; Bogdanet D; Desoye G; Dunne F; Halperin JA;
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1033-40. PubMed ID: 32069353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes.
    Benhalima K; Ma DD; Laenen A; Mathieu C; Halperin JA
    Eur J Endocrinol; 2021 Oct; 185(5):755-763. PubMed ID: 34524975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol.
    Andrews C; Toth-Castillo M; Aktas H; Fernandez ML; Wong SK; Sen S; Halperin J
    BMJ Open; 2022 Apr; 12(4):e054773. PubMed ID: 35443950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia-Subanalysis of the DALI Study.
    Bogdanet D; Luque-Fernandez MA; Toth-Castillo M; Desoye G; O'Shea PM; Dunne FP; Halperin JA
    J Clin Endocrinol Metab; 2022 Nov; 107(11):e4311-e4319. PubMed ID: 36054347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) - protocol for prospective cohort study.
    Bogdanet D; O'Shea PM; Halperin J; Dunne F
    BMC Pregnancy Childbirth; 2020 Jul; 20(1):412. PubMed ID: 32682411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the cut-off value of the first trimester fasting plasma glucose level and gestational diabetes mellitus: a retrospective study from southern China.
    Tong JN; Chen YX; Guan XN; Liu K; Yin AQ; Zhang HF; Wu LL; Niu JM
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):540. PubMed ID: 35787265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal hyperglycemia in singleton pregnancies conceived by IVF may be modified by first-trimester BMI.
    Cai S; Natarajan P; Chan JKY; Wong PC; Tan KH; Godfrey KM; Gluckman PD; Shek LPC; Yap F; Kramer MS; Chan SY; Chong YS
    Hum Reprod; 2017 Sep; 32(9):1941-1947. PubMed ID: 28854717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China.
    Wei Y; Juan J; Su R; Song G; Chen X; Shan R; Li Y; Cui S; Fan S; Feng L; You Z; Meng H; Cai Y; Zhang C; Yang H
    Chin Med J (Engl); 2022 Mar; 135(6):665-671. PubMed ID: 35348312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance.
    Ghosh P; Luque-Fernandez MA; Vaidya A; Ma D; Sahoo R; Chorev M; Zera C; McElrath TF; Williams MA; Seely EW; Halperin JA
    Diabetes Care; 2017 Jul; 40(7):981-984. PubMed ID: 28450368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of mild gestational hyperglycemia and gestational diabetes mellitus in a large dutch multiethnic cohort.
    Weijers RN; Bekedam DJ; Smulders YM
    Diabetes Care; 2002 Jan; 25(1):72-7. PubMed ID: 11772904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk-prediction model using parameters of maternal body composition to identify gestational diabetes mellitus in early pregnancy.
    Cremona A; O'Gorman CS; Ismail KI; Hayes K; Donnelly AE; Hamilton J; Cotter A
    Clin Nutr ESPEN; 2021 Oct; 45():312-321. PubMed ID: 34620334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of gestational diabetes mellitus before and after the introduction of HAPO diagnostic criteria.
    Krejčí H; Šimják P; Anderlová K; Benáková H; Pařízek A; Krejčí V; Škrha J
    Ceska Gynekol; 2019; 84(6):404-411. PubMed ID: 31948247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester HbA
    Jokelainen M; Kautiainen H; Nenonen A; Stach-Lempinen B; Klemetti MM
    Diabetol Metab Syndr; 2024 Feb; 16(1):53. PubMed ID: 38414049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome.
    Odsæter IH; Åsberg A; Vanky E; Carlsen SM
    BMC Endocr Disord; 2015 Aug; 15():38. PubMed ID: 26245653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated oral glucose tolerance tests in women at risk for gestational diabetes mellitus.
    de Wit L; Bos DM; van Rossum AP; van Rijn BB; Boers KE
    Eur J Obstet Gynecol Reprod Biol; 2019 Nov; 242():79-85. PubMed ID: 31569028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of gestational diabetes mellitus in Nigerian pregnant women--comparison between 75G and 100G oral glucose tolerance tests.
    Olarinoye JK; Ohwovoriole AE; Ajayi GO
    West Afr J Med; 2004; 23(3):198-201. PubMed ID: 15587828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.